Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Top Cited Papers
Open Access
- 1 April 2015
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 385 (9975) , 1295-1304
- https://doi.org/10.1016/s0140-6736(14)62111-5
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A Randomized Trial of Brimonidine Versus Timolol in Preserving Visual Function: Results From the Low-pressure Glaucoma Treatment StudyAmerican Journal of Ophthalmology, 2011
- The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placeboVision Research, 2010
- Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucomaCurrent Medical Research and Opinion, 2010
- Intraocular Pressure (IOP) Reduction by Latanoprost in Japanese Normal Tension Glaucoma Patients Over a Five-Year Period Stratified by Presenting IOPJournal of Ocular Pharmacology and Therapeutics, 2009
- Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study: The Impact of Treatment and Other Baseline FactorsPublished by Elsevier ,2008
- Glaucoma and Mobility PerformanceOphthalmology, 2007
- Medical interventions for primary open angle glaucoma and ocular hypertensionCochrane Database of Systematic Reviews, 2007
- Causes of blind certifications in England and Wales: April 1999–March 2000Eye, 2007
- Early trabeculectomy versus conventional management in primary open angle glaucoma.British Journal of Ophthalmology, 1988
- Treatment versus no treatment in chronic open angle glaucomaActa Ophthalmologica, 1988